Latest news with #CCPs
Yahoo
4 days ago
- Business
- Yahoo
Managing Clearing, Settlement and Counterparty Risk Training Course (ONLINE EVENT: June 12, 2025)
Learn how to manage counterparty risk with our one-day course on clearing and settlement processes for derivatives and securities. Led by an industry expert, the training covers CCP roles, margining systems, and post-financial crisis risk mitigation. Optimize your knowledge today! Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Clearing, Settlement and Counterparty Risk" training has been added to offering. The Course Leader for this training course has been working in the derivatives industry for 30 years and regularly teaches on behalf of the world's leading clearing houses and stock exchanges. These institutions are vital to managing counterparty risk. In recent years a lot of attention has been focused on the subject of post trade environment - clearing and settlement. This informative and easy to follow one day course, has been specially designed to explain how the clearing and settlement process works for derivatives and securities, demonstrating how banks and their clients manage their counterparty risk - which is particularly important in the post financial era. You will learn about the role of Central Counter Party (CCP) otherwise known as the Clearing House, and its role to mitigate counterparty risk, as well as relationships between end users, clearing members and the CCP. You will also learn how the risk is mitigated through the process of margining. The course also shows in some detail, how the margining system allows for the netting of risk and the effective management of collateral. What will you learn By the end of this course you will be able to: Understand the significance of counterparty risk, especially post financial crisis Explain the role and function of the Central Clearing Counterparty (CCP) Illustrate the relationship between clearing members and clients and show how different types of client accounts can be set up and managed Demonstrate how CCPs and central security depositories (CSDs) interact Show how CCPs are structured and explain their "lines of defence" Describe how listed derivatives v OTC derivatives are collateralised and cleared Show how the margining system works for futures and options and other derivatives like swaps compared with bonds and equities Illustrate the benefit of portfolio based margining systems like SPAN and VaR margining methodology Who Should Attend: Clearing houses Prime Brokers and Derivative Clearing Brokers Clearing and Settlement Custodians Counterparty Risk Management Back and Middle Office Operations Fund Administrators Compliance and Risk Management Audit IT Key Topics Covered: Counterparty risk in the post financial crisis environment Central clearing counterparties (CCPs) and clearing members Margining for futures (linear products) and options (non-linear), other derivatives and securities Central security depositories (CSD) For more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
10-03-2025
- Business
- Yahoo
Lab-grown food could be sold in the UK within two years
Lab-grown food could be sold in the UK within two years, a watchdog has indicated. The Food Standards Agency (FSA) said it was committed to completing the full safety assessment of two cell-cultivated products (CCPs) within the next two years. The watchdog has launched a 'pioneering' regulatory programme for CCPs to make sure they are safe for consumers before they are sold, funded by the Department of Science, Innovation and Technology's Engineering Biology Sandbox Fund. CCPs are new food products made without traditional farming methods such as rearing livestock or growing plants and grains. Instead, cells from plants or animals are grown in a controlled environment to make the product. There are currently no CCPs approved for human consumption in the UK. FSA chief scientific adviser Professor Robin May said: 'Safe innovation is at the heart of this programme. 'By prioritising consumer safety and making sure new foods, like CCPs, are safe we can support growth in innovative sectors. 'Our aim is to ultimately provide consumers with a wider choice of new food, while maintaining the highest safety standards.' A team of scientists and regulatory experts will work with academic bodies, the CCP industry and trade organisations on the two-year programme. Science minister Lord Vallance said: 'By supporting the safe development of cell-cultivated products, we're giving businesses the confidence to innovate and accelerating the UK's position as a global leader in sustainable food production. 'This work will not only help bring new products to market faster, but strengthen consumer trust, supporting our Plan for Change and creating new economic opportunities across the country.' The businesses participating in the programme are Hoxton Farms, Roslin Technologies and Uncommon Bio, all from the UK, BlueNalu (US), Mosa Meat (the Netherlands), Gourmey and Vital Meat (France) and Vow (Australia). Hoxton Farms was launched in 2020 by Ed Steele and Max Jamilly, and has been pioneering technology to grow animal fat products that 'look, cook and taste like the real thing'. Roslin Technologies was launched two years later as a biotech company to produce lab-grown pet food. In February, a dog treat made from cultivated meat went on sale at Pets at Home in a move the retailer claimed was a world first. In July last year, the UK became the first country in Europe to back cultivated meat for use in pet food, after chicken produced by the firm Meatly was approved by the Department for Environment, Food and Rural Affairs and the Animal and Plant Health Agency. The treat, called Chick Bites, is made from plant-based ingredients combined with cultivated meat, which is produced by growing cells and does not require the raising or slaughter of animals. Meatly said the chicken was produced from a single sample of cells taken from one chicken egg, from which enough cultivated meat could be produced to feed pets 'forever'.
The Independent
10-03-2025
- Business
- The Independent
Lab-grown food could be sold in the UK within two years
Lab-grown food could be sold in the UK within two years, a watchdog has indicated. The Food Standards Agency (FSA) said it was committed to completing the full safety assessment of two cell-cultivated products (CCPs) within the next two years. The watchdog has launched a 'pioneering' regulatory programme for CCPs to make sure they are safe for consumers before they are sold, funded by the Department of Science, Innovation and Technology's Engineering Biology Sandbox Fund. CCPs are new food products made without traditional farming methods such as rearing livestock or growing plants and grains. Instead, cells from plants or animals are grown in a controlled environment to make the product. There are currently no CCPs approved for human consumption in the UK. FSA chief scientific adviser Professor Robin May said: 'Safe innovation is at the heart of this programme. 'By prioritising consumer safety and making sure new foods, like CCPs, are safe we can support growth in innovative sectors. 'Our aim is to ultimately provide consumers with a wider choice of new food, while maintaining the highest safety standards.' A team of scientists and regulatory experts will work with academic bodies, the CCP industry and trade organisations on the two-year programme. Science minister Lord Vallance said: 'By supporting the safe development of cell-cultivated products, we're giving businesses the confidence to innovate and accelerating the UK's position as a global leader in sustainable food production. 'This work will not only help bring new products to market faster, but strengthen consumer trust, supporting our Plan for Change and creating new economic opportunities across the country.' The businesses participating in the programme are Hoxton Farms, Roslin Technologies and Uncommon Bio, all from the UK, BlueNalu (US), Mosa Meat (the Netherlands), Gourmey and Vital Meat (France) and Vow (Australia). Hoxton Farms was launched in 2020 by Ed Steele and Max Jamilly, and has been pioneering technology to grow animal fat products that 'look, cook and taste like the real thing'. Roslin Technologies was launched two years later as a biotech company to produce lab-grown pet food. In February, a dog treat made from cultivated meat went on sale at Pets at Home in a move the retailer claimed was a world first. In July last year, the UK became the first country in Europe to back cultivated meat for use in pet food, after chicken produced by the firm Meatly was approved by the Department for Environment, Food and Rural Affairs and the Animal and Plant Health Agency. The treat, called Chick Bites, is made from plant-based ingredients combined with cultivated meat, which is produced by growing cells and does not require the raising or slaughter of animals. Meatly said the chicken was produced from a single sample of cells taken from one chicken egg, from which enough cultivated meat could be produced to feed pets 'forever'.
